IPSC logo

Century Therapeutics (IPSC) Company Overview

Profile

Full Name:

Century Therapeutics, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

June 18, 2021

Indexes:

Not included

Description:

IPSC (Century Therapeutics) focuses on developing innovative cell therapies using induced pluripotent stem cells. Their goal is to create personalized treatments for various diseases, including cancer, by harnessing the potential of these versatile cells to generate immune cells that can target and destroy tumors effectively.

Events Calendar

Earnings

Next earnings date:

Mar 14, 2025

Recent quarterly earnings:

Nov 5, 2024

Recent annual earnings:

Mar 14, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Jan 22, 25 HC Wainwright & Co.
Buy
Jan 22, 25 Guggenheim
Buy
Dec 30, 24 Piper Sandler
Overweight
Nov 7, 24 Chardan Capital
Buy
Nov 6, 24 HC Wainwright & Co.
Buy
Aug 15, 24 HC Wainwright & Co.
Buy
Jun 17, 24 Piper Sandler
Overweight
Jun 4, 24 HC Wainwright & Co.
Buy
May 10, 24 HC Wainwright & Co.
Buy
Apr 12, 24 Piper Sandler
Overweight

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Century Therapeutics?
  • Does Century Therapeutics pay dividends?
  • What sector is Century Therapeutics in?
  • What industry is Century Therapeutics in?
  • What country is Century Therapeutics based in?
  • When did Century Therapeutics go public?
  • Is Century Therapeutics in the S&P 500?
  • Is Century Therapeutics in the NASDAQ 100?
  • Is Century Therapeutics in the Dow Jones?
  • When was Century Therapeutics's last earnings report?
  • When does Century Therapeutics report earnings?
  • Should I buy Century Therapeutics stock now?

What is the ticker symbol for Century Therapeutics?

The ticker symbol for Century Therapeutics is NASDAQ:IPSC

Does Century Therapeutics pay dividends?

No, Century Therapeutics does not pay dividends

What sector is Century Therapeutics in?

Century Therapeutics is in the Healthcare sector

What industry is Century Therapeutics in?

Century Therapeutics is in the Biotechnology industry

What country is Century Therapeutics based in?

Century Therapeutics is headquartered in United States

When did Century Therapeutics go public?

Century Therapeutics's initial public offering (IPO) was on June 18, 2021

Is Century Therapeutics in the S&P 500?

No, Century Therapeutics is not included in the S&P 500 index

Is Century Therapeutics in the NASDAQ 100?

No, Century Therapeutics is not included in the NASDAQ 100 index

Is Century Therapeutics in the Dow Jones?

No, Century Therapeutics is not included in the Dow Jones index

When was Century Therapeutics's last earnings report?

Century Therapeutics's most recent earnings report was on Nov 5, 2024

When does Century Therapeutics report earnings?

The next expected earnings date for Century Therapeutics is Mar 14, 2025

Should I buy Century Therapeutics stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions